BenevolentAI (AMS: BAI) is a leading developer of advanced artificial intelligence technologies that unlock the value of multimodal data, surface novel insights, and accelerate biomedical discovery.
Through the combined capabilities of its AI platform, its scientific expertise, and wet-lab facilities, the Company is developing an inhouse drug pipeline of high-value assets. The Company is headquartered in London, with a research facility in Cambridge (UK) and a further office in New York.
Press contacts
FTI Consulting
Ben Atwell, Simon Conway, Victoria Foster Mitchell
BenevolentAI@fticonsulting.com
+44 (0) 20 3727 1000
Useful Links
Images
Sign up for our news